FIRST EXPERT WEBINAR

Abeona has offered an expert webinar on “GENE THERAPY CLINICAL TRIALS FOR MUCOPOLYSACCHARIDOSIS (MPS) TYPES IIIA AND IIIB*”

Given the current situation that has forced to move the MPS International Symposium to the summer of 2021, and the cancellation of many annual MPS Meetings at national level, we wanted to offer a platform to facilitate knowledge sharing and information regarding news and developments on MPS and related diseases.

 Thus, we are pleased to present the first EXPERT WEBINAR organized together with ABEONA THERAPEUTICS, which took place on July 23 and featured simultaneous translation into Spanish, Mandarin Chinese and Japanese. If you could not attend the live webcast, you can watch it now following this LINK.

PROGRAM

About Abeona
João Siffert, M.D.
CEO Abeona Therapeutics

MPS Pathophysiology & Gene Therapy MOA
Kevin Flanigan, M.D.
Director, Center for Gene Therapy at Nationwide Children’s Hospital, Professor of Pediatrics and Endowed Chair in Neuromuscular Research Ohio State
Investigator for the Transpher A study, Transpher B study

MPS IIIA Natural-History Data Studies
Maria Escolar, M.D., M.S.
Director, Program for the Study of Neurodevelopment in Rare Disorders and Professor of Pediatrics, University of Pittsburgh
Investigator for the Transpher A study, study ABT-003

Study Results to Date (last presented at ASGCT 2020)
Kevin Flanigan, M.D.

Study Overview
Maria Escolar, M.D., M.S.

Q&A Session

We hope this will help the MPS community stay up to date on industry developments & news!

*Abeona Therapeutics sponsored studies. Search “mucopolysaccharidosis” at ClinicalTrials.gov for full study listing. Brought to you by the International MPS Society and Abeona.

2020-07-30 00:00:00

New dates for MPS International Symposium

We are pleased to announce that the International MPS Network and MPS Spain have approved the new dates for the 16th International Symposium on MPS & Related Diseases, which will take place from Friday, July 30 till Sunday, August 1, 2021.

The International Symposium will be held at the Hyatt Regency Barcelona Tower, the same venue where it was scheduled to take place this year.

Registration to attend the Symposium will reopen after the summer. Exact dates will be announced through this newsletter and the International MPS Network.  

During this week we contacted all attendees who had already registered and reserved their accommodation for this summer. Please allow us time to process refunds for all who have requested it.

As you know, protecting the health, safety and well-being of all the attendees was at the heart of the decision to postpone the MPS International Symposium. Thank you all for your support and understanding.

We would like to use this opportunity to send special thanks to all the sponsors of the Symposium for their continue support and for standing by the MPS community in this difficult decision.  

Platinum Sponsors

   

Other Sponsors

Abeona Therapeutics
Chiesi
Inventiva Pharma
JCR Pharmaceuticals
Lysogene
Orchard Therapeutics
Regenxbio
Sangamo Therapeutics
Serepta Therapeutics
Sigilon Therapeutics
Ultragenyx Pharmaceutical

We look forward to welcome you in Barcelona next summer 2021!

2020-04-07 00:00:00